Wolfram syndrome (DIDMOAD)
Log in to starLast updated Nov 3, 2026
A teenager with type 1 diabetes is found to have progressive vision loss (optic atrophy). Audiometry reveals sensorineural hearing loss. Urological workup shows diabetes insipidus.
AR; WFS1, encoding wolframin, a transmembrane glycoprotein of the endoplasmic reticulum. Biallelic variants cause loss of wolframin function. Heterozygous WFS1 variants cause nonclassic disease, the milder autosomal dominant end of the same spectrum.
Wolfram syndrome is considered a prototype of endoplasmic reticulum (ER) disease. WFS1 encodes wolframin, a glycoprotein that spans the ER membrane. Its precise function has not been established, but its deficiency is thought to cause ER stress, impair cell cycle progression, and disturb calcium homeostasis.
- Classic disease (AR): biallelic variants cause loss of wolframin function. Diabetes mellitus and optic atrophy usually begin before age 16 years. Hearing loss ranges from congenital to later onset (median 12.5 years in one report); central diabetes insipidus, neurogenic bladder, and neurologic decline from generalized brain atrophy, most prominent in the cerebellum, medulla, and pons, follow later. Heterozygous parents show no conclusive increase in risk for any of these features.
- Nonclassic disease (AD): a single heterozygous variant, usually de novo, causes milder pictures that appear nonprogressive or only slowly progressive: optic atrophy with hearing loss, isolated diabetes, isolated cataracts, or low-frequency hearing loss.
No genotype-phenotype correlation has been identified, and the course varies even between sibs with the same variants, so the variant does not predict severity. Wolfram syndrome type 2 is a different gene, CISD2, whose protein does not interact directly with wolframin.
DIDMOAD mnemonic:
- Diabetes Insipidus
- Diabetes Mellitus (non-autoimmune)
- Optic Atrophy
- Deafness (sensorineural)
Other features: neurological degeneration, urinary tract abnormalities
- Suspect with the combination of non-autoimmune (antibody-negative) diabetes mellitus and optic atrophy, the minimal diagnostic dyad
- Document associated features: central diabetes insipidus (water deprivation testing), sensorineural hearing loss (audiometry), and urinary tract dilation
- Confirm with WFS1 sequencing (autosomal recessive); CISD2 in Wolfram syndrome type 2
- No disease-modifying therapy; care is supportive and multidisciplinary (endocrinology, ophthalmology, audiology, urology, neurology)
- Insulin for diabetes mellitus; desmopressin for central diabetes insipidus; hearing aids for sensorineural hearing loss
- Surveillance for progressive neurodegeneration, neurogenic bladder, and psychiatric manifestations
- Genetic counseling: autosomal recessive, 25% recurrence risk for siblings